Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Co-Diagnostics Inc.

    NASDAQ: CODX · Real-Time Price · USD
    0.30
    -0.00 (-1.38%)
    At close: Jun 06, 2025, 3:59 PM
    0.31
    3.27%
    After-hours: Jun 06, 2025, 05:34 PM EDT

    Co-Diagnostics Statistics

    Share Statistics

    Co-Diagnostics has 33.71M shares outstanding. The number of shares has increased by 2.08% in one year.

    Shares Outstanding

    n/a
    		 33.71M

    Shares Change (YoY)

    n/a
    		 2.08%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 18.76%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 378

    FTD / Avg. Volume

    n/a
    		 0.11%

    Short Selling Information

    The latest short interest is 166.1K, so 0.49% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 166.1K

    Short % of Shares Out

    n/a
    		 0.49%

    Short % of Float

    n/a
    		 0.53%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.6 and the forward PE ratio is -0.69. Co-Diagnostics's PEG ratio is -0.18.

    PE Ratio

    n/a
    		 -0.6

    Forward PE

    n/a
    		 -0.69

    PS Ratio

    n/a
    		 5.81

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 0.42

    P/FCF Ratio

    n/a
    		 -0.76

    PEG Ratio

    n/a
    		 -0.18
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Co-Diagnostics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.41, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 4.41

    Quick Ratio

    n/a
    		 4.27

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.06

    Debt / FCF

    n/a
    		 -0.07

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $29,660.3

    Profits Per Employee

    n/a
    		 $-285,144

    Employee Count

    n/a
    		 132

    Asset Turnover

    n/a
    		 0.06

    Inventory Turnover

    n/a
    		 0.93

    Taxes

    Income Tax

    n/a
    		 57.37K

    Effective Tax Rate

    n/a
    		 -0.15%

    Stock Price Statistics

    The stock price has increased by -79.02% in the last 52 weeks. The beta is 0.84, so Co-Diagnostics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.84

    52-Week Price Change

    n/a
    		 -79.02%

    50-Day Moving Average

    n/a
    		 0.33

    200-Day Moving Average

    n/a
    		 0.81

    Relative Strength Index (RSI)

    n/a
    		 49.89

    Average Volume (20 Days)

    n/a
    		 339,436

    Income Statement

    In the last 12 months, Co-Diagnostics had revenue of 3.92M and earned -37.64M in profits. Earnings per share was -1.24.

    Revenue

    n/a
    		 3.92M

    Gross Profit

    n/a
    		 2.92M

    Operating Income

    n/a
    		 -40.08M

    Net Income

    n/a
    		 -37.64M

    EBITDA

    n/a
    		 -38.7M

    EBIT

    n/a
    		 -40.08M

    Earnings Per Share (EPS)

    n/a
    		 -1.24
    Full Income Statement

    Balance Sheet

    The company has 2.94M in cash and 2.15M in debt, giving a net cash position of 784.37K.

    Cash & Cash Equivalents

    n/a
    		 2.94M

    Total Debt

    n/a
    		 2.15M

    Net Cash

    n/a
    		 784.37K

    Retained Earnings

    n/a
    		 -33.04M

    Total Assets

    n/a
    		 55.15M

    Working Capital

    n/a
    		 18.45M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -29.16M and capital expenditures -748.35K, giving a free cash flow of -29.9M.

    Operating Cash Flow

    n/a
    		 -29.16M

    Capital Expenditures

    n/a
    		 -748.35K

    Free Cash Flow

    n/a
    		 -29.9M

    FCF Per Share

    n/a
    		 -0.99
    Full Cash Flow Statement

    Margins

    Gross margin is 74.48%, with operating and profit margins of -1023.75% and -961.37%.

    Gross Margin

    n/a
    		 74.48%

    Operating Margin

    n/a
    		 -1023.75%

    Pretax Margin

    n/a
    		 -959.9%

    Profit Margin

    n/a
    		 -961.37%

    EBITDA Margin

    n/a
    		 -988.57%

    EBIT Margin

    n/a
    		 -1023.75%

    FCF Margin

    n/a
    		 -763.78%

    Dividends & Yields

    CODX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CODX is $5.5, which is 1733.3% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $5.5

    Price Target Difference

    n/a
    		 1733.3%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.32

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist